Back to search

United Kingdom· GB-APID-38621611000001109

Metaraminol 2.5mg/5ml solution for injection ampoules

A metaraminol product containing metaraminol, registered in United Kingdom by Torbay Pharmaceuticals. The same ATC class is registered in 3 of our 19 countries.

ATC C01CA09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedMetaraminol 2.5mg/5ml solution for in…ATCC01CA09REGISTER NO.GB-APID-3862161100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Metaraminol is registered in 3 of 19 countries.

Countries holding a registration under ATC C01CA09 (metaraminol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 1 of them publish a price we can compare per daily dose

Metaraminol · ATC C01CA09

3 / 19 countries

  • Finlandprice
  • Ireland
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Metaraminol
Manufacturer
Torbay Pharmaceuticals
Country
United Kingdom (GB)
ATC code
C01CA09
ATC class
Metaraminol
Defined daily dose
50 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060131263700

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

87 interactions on record for metaraminol.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metaraminol · interactions on record

87 records

  • 7 severe
  • 80 moderate

Most severe, free to view

  • ProcarbazineL01XB01severe
  • CocaineN01BC01severe
  • DoxepinN06AA12severe
  • CocaineR02AD03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Metaraminol in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metaraminol products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Italy · Metaraminolo Monico 10 Mg/Ml

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f62a302f-ef3b-4185-b48e-bafd3e23d85b
GET /v1/drugs/f62a302f-ef3b-4185-b48e-bafd3e23d85b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "38621611000001109",
  "desc": "Metaraminol 2.5mg/5ml solution for injection ampoules (Torbay Pharmaceuticals)",
  "form": "Solution for injection",
  "vpid": "25639511000001100",
  "source": "dmd",
  "vtm_id": "776710009",
  "strength": "500 microgram",
  "substance": "Metaraminol",
  "ingredient": "Metaraminol tartrate",
  "supplier_code": "27184311000001100"
}

See everything about metaraminol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.